Records containing: Major Depressive Disorder
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2013-04-04rTMS for Adolescent and Young Adult Depression
-
CLINICAL_TRIALS study record update · 2013-04-04Decreasing the Use of Unmodified ECT in an Indian Hospital
-
CLINICAL_TRIALS study record update · 2013-03-22Augmentation of the Antidepressant Action of Sertraline With Triiodothyronine (T3)and Reboxetine: Clinical Efficacy, Adverse Effects and Predictors of Response.
-
CLINICAL_TRIALS study record update · 2013-03-15An Eight-week, Multicenter, Randomized, Double-blind, Placebo-controlled Dose-finding Study, With Escitalopram (10 mg Daily) as Active Control, to Evaluate the Efficacy, Safety and Tolerability of Three Fixed Doses of SSR411298 (10, 50, or 200 mg Daily) in Elderly Patients With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2013-02-27A Controlled Study of Ultrabrief Pulsewidth ECT (Electroconvulsive Therapy)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2013-02-22Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) Study
-
CLINICAL_TRIALS study record update · 2013-02-20The Metabolic Effects of Antidepressants in Patients Diagnosed With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2013-02-08Neural Correlates of Emotional Processing in Depressed and Remitted Bipolar and Unipolar Depressed Subjects: An fMRI Investigation
-
CLINICAL_TRIALS study record update · 2013-01-25Comparison of Tianeptine Versus Escitalopram for the Treatment of Depression and Cognitive Impairment in Patients With Major Depressive Disorder: A Randomized, Multicenter, Open-label Study
-
CLINICAL_TRIALS study record update · 2013-01-18Effectiveness of Deep Transcranial Magnetic Stimulation for Treating Major Depression: a Pilot Study
-
CLINICAL_TRIALS study record update · 2013-01-14Harnessing the Placebo Effect in Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2013-01-11Study of Cerebral Function in Patients With Chronic Hepatitis C Infection Before and After Pegylated Interferon Alfa-2a and Ribavirin Therapy
-
CLINICAL_TRIALS study record update · 2013-01-10Algorithm Guided Treatment Strategies for Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2013-01-08QEEG Predictors of Response for Psychotherapy Compared to Pharmacotherapy in Depression
-
CLINICAL_TRIALS study record update · 2012-12-13A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
-
CLINICAL_TRIALS study record update · 2012-12-11Randomized, Placebo-controlled Trial of an AMPAkine in Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2012-11-21Associations Between Depression and Cardiovascular Disease in Patients With Late Onset, Single Episode Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2012-11-20A Multicenter, Randomized, Double-Blind Parallel Group Placebo-Controlled Phase III,Efficacy and Safety Study of 3 Fixed Dose Groups of TC-5214 (S-mecamylamine) as an Adjunct to an Antidepressant in Patients With Major Depressive Disorder Who Exhibit an Inadequate Response to Antidepressant Therapy
-
CLINICAL_TRIALS study record update · 2012-11-20A Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Phase III Efficacy and Safety Study of TC-5214 (S-mecamylamine) in Flexible Doses as an Adjunct to an Antidepressant in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Therapy
-
CLINICAL_TRIALS study record update · 2012-11-20A Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Phase III Efficacy and Safety Study of TC-5214 (S-mecamylamine) in Flexible Doses as an Adjunct to an Antidepressant in Patients With Major Depressive Disorder Who Exhibit an Inadequate Response to Antidepressant Therapy
-
CLINICAL_TRIALS study record update · 2012-11-16Psychosocial Treatment of Depression in Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2012-11-01The Effect of Quetiapine XR in Depressive Patients Showing Aberrant N100 Amplitude Slope
-
CLINICAL_TRIALS study record update · 2012-10-29A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Active Controlled, Parallel Group, Multicenter Study to Assess the Safety and Efficacy of 2 Fixed Dose Groups of TC-5214 (S-mecamylamine) as Monotherapy Treatment in Patients With Major Depressive Disorder Who Exhibit an Inadequate Response to Antidepressant Therapy
-
CLINICAL_TRIALS study record update · 2012-10-29A Multicenter, Randomized, Double-Blind Parallel Group Placebo-Controlled Phase III, Efficacy and Safety Study of 3 Fixed Dose Groups of TC-5214 (S-mecamylamine) as an Adjunct to an Antidepressants in Patients With Major Depressive Disorder Who Exhibit an Inadequate Response to Antidepressant Therapy
-
CLINICAL_TRIALS study record update · 2012-10-29A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III, Long-Term Safety and Tolerability Study of TC-5214 (S-mecamylamine) as an Adjunct to an Antidepressant in Patients With Major Depressive Disorder Who Exhibit an Inadequate Response to Antidepressant Therapy